An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
Clinical trial NCT01103960 · COMPLETED
Trial details
- NCT number
- NCT01103960
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.